The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource

Arja, Mohammad H Abu; Stanek, Joseph; Madrid, Andrés E Morales La; Lassaletta, Álvaro; Bartels, Ute; Qaddoumi, Ibrahim; Finlay, Jonathan L.; Osorio, Diana S

doi:10.1007/s00381-018-4000-x

Cited by 14 publications

(19 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The participants expressed their high statisfaction with the discussions in the Tumor Boards, considered the given recommendations almost uniformly helpful, and used the participation in the LATB as part of the continuous medical education. This is reflected by the presenters’ plans to review further cases at Tumor Board rounds, by previous excellent evaluation of the LATB 14 and by the excellent evaluation of “educational topics” with detailed medical explanations among the recommendations. Moreover, the community of participants in the LATB grows fast, with many participants joining the sessions without necessarily presenting their own cases 13 .…”

Section: Discussionmentioning

confidence: 99%

“…Both number of participants and cases presented in the LATB increased substantially in the years following 2013 13 . Physicians participating in the LATB reported that they found the recommendations helpful and thereby helped to improve the outcomes of their patients 14 . However, a structured follow‐up of the presented cases is unavailable and it therefore remains unclear to what extent the recommendations can be implemented under real circumstances.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Follow‐up evaluation of a web‐based pediatric brain tumor board in Latin America

Rosabal-Obando

Osorio

Lassaletta

et al. 2021

Pediatric Blood & Cancer

Self Cite

View full text Add to dashboard Cite

Background: Since 2013, pediatric oncologists from Central and South America discuss neuro-oncology cases with experts from North America and Europe in a webbased "Latin American Tumor Board" (LATB). Here, we evaluate the feasibility of recommendations rendered by the Board.Methods: An electronic questionnaire was distributed to physicians who had received recommendations between October 2017 and October 2018. Physicians were asked regarding the feasibility of each recommendation given during the LATB discussion.Baseline case characteristics of all presented cases were obtained from anonymized minutes.Results: Of the 142 patients discussed, data on 103 patients from 15 countries were available, corresponding to 283 recommendations. Physicians followed 60% of diagnostic procedural recommendations and 69% of therapeutic recommendations. The most difficult recommendations to follow were genetic and molecular testing, pathology review, chemotherapy, surgery, and molecular targeted therapies. Histological diagnoses changed in eight of 18 cases in which a pathology review was undertaken.Fifty-four percent of the recommendations that could not be implemented were considered not feasible in the specific context of the patient, while 31% were not implemented due to a decision of the medical staff or the parents (15% not specified). However, 96% of respondents considered the recommendations useful. Conclusion:Recommendations were frequently perceived as useful, and were applicable in the participating institutions. Nevertheless, limitations in availability of diagnostic procedures and treatment modalities affected the feasibility of some recommendations. Tele-oncology tumor boards offer physicians from low-and middleincome countries access to real-time, high-level subspecialist expertise and provide a valuable platform for worldwide information exchange.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Follow‐up evaluation of a web‐based pediatric brain tumor board in Latin America

Rosabal-Obando

Osorio

Lassaletta

et al. 2021

Pediatric Blood & Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

“…Six types of team collaboration in oncology care were distinguished (table 1): (1) Expert MDTM-national: provides expertise and experience on rare tumours nationally (17 studies) 18-34 ; (2) Expert MDTM-International: provides international expertise and experience on rare tumours (5 studies) [35][36][37][38][39] ; (3) Expert Consultation: physicians caring for complex patients seeking a consultation with experts (11 studies) [40][41][42][43][44][45][46][47][48][49][50] ; (4) Consultation Specialist-Nurse: nurses consulting with palliative treatment specialists in specialised palliative care units or hospices (4 studies) [51][52][53][54] ; (5) MDT-Equal: involving more or less equal MDTs that use each other for a 'fresh look' to optimise the diagnostic and treatment plans for complex cases (5 studies) [55][56][57][58][59] ; and (6) MDTM-Collaborate: MDTs collaborating to form one MDTM (8 studies) [60][61][62][63][64][65][66][67] (online supplemental file 5).…”

Section: Thematic Analysis and Synthesis Of Subsetsmentioning

confidence: 99%

Benefits and drawbacks of videoconferencing for collaborating multidisciplinary teams in regional oncology networks: a scoping review

et al. 2021

View full text Add to dashboard Cite

IntroductionVarious forms of videoconferenced collaborations exist in oncology care. In regional oncology networks, multidisciplinary teams (MDTs) are essential in coordinating care in their region. There is no recent overview of the benefits and drawbacks of videoconferenced collaborations in oncology care networks. This scoping review presents an overview of videoconferencing (VC) in oncology care and summarises its benefits and drawbacks regarding decision-making and care coordination.DesignWe searched MEDLINE, Embase, CINAHL (nursing and allied health) and the Cochrane Library from inception to October 2020 for studies that included VC use in discussing treatment plans and coordinating care in oncology networks between teams at different sites. Two reviewers performed data extraction and thematic analyses.ResultsFifty studies were included. Six types of collaboration between teams using VC in oncology care were distinguished, ranging from MDTs collaborating with similar teams or with national or international experts to interactions between palliative care nurses and experts in that field. Patient benefits were less travel for diagnosis, better coordination of care, better access to scarce facilities and treatment in their own community. Benefits for healthcare professionals were optimised treatment plans through multidisciplinary discussion of complex cases, an ability to inform all healthcare professionals simultaneously, enhanced care coordination, less travel and continued medical education. VC added to the regular workload in preparing for discussions and increased administrative preparation.DiscussionBenefits and drawbacks for collaborating teams were tied to general VC use. VC enabled better use of staff time and reduced the time spent travelling. VC equipment costs and lack of reimbursement were implementation barriers.ConclusionVC is highly useful for various types of collaboration in oncology networks and improves decision-making over treatment plans and care coordination, with substantial benefits for patients and specialists. Drawbacks are additional time related to administrative preparation.

show abstract

“…The Latin American Brain Tumor Board (LATB), a weekly multidisciplinary pediatric neuro‐oncology‐specific teleconference, connects institutions from Latin America with those in Canada, Spain, and the United States. The LATB is an example of how collaborative efforts between HIC and LMIC can improve care by giving real‐time recommendations to oncologists in LMIC institutions 46 . As with any retrospective study, this work has several limitations, with data missing from some variables of interest.…”

Section: Discussionmentioning

confidence: 99%

Factors influencing outcomes of older children with medulloblastoma over 15 years in Peru, a resource‐limited setting

Coronado

Reinecke

Stanek

et al. 2022

Pediatric Blood & Cancer

Self Cite

View full text Add to dashboard Cite

Background: Medulloblastoma is the most common malignant brain tumor in children. While survival has improved in high-income countries (HIC), the outcomes for patients in low-to-middle-income countries (LMIC) are unclear. Therefore, we sought to determine the survival of children with medulloblastoma at the Instituto Nacional de Enfermedades Neoplasicas (INEN) between 1997 and 2013 in Peru. Methods: Between 1997 and 2013, data from 103 children older than 3 years with medulloblastoma were analyzed. Fourteen patients were excluded. The patients were split into two distinct cohorts, 1997-2008 and 2009-2013, corresponding with chemotherapy regimen changes. Event-free (EFS) and overall survival (OS) were calculated using the Kaplan-Meier method, whereas prognostic factors were determined by univariate analysis (log-rank test).Results: Eighty-nine patients were included; median age was 8.1 years (range: 3-13.9 years). The 5-year OS was 62% (95% CI: 53%-74%), while EFS was 57% (95% CI: 48%-69%). The variables adversely affecting survival were anaplastic histology

show abstract

The Latin American Brain Tumor Board teleconference: results of a web-based survey to evaluate participant experience utilizing this resource

Cited by 14 publications

References 29 publications

Follow‐up evaluation of a web‐based pediatric brain tumor board in Latin America

Follow‐up evaluation of a web‐based pediatric brain tumor board in Latin America

Benefits and drawbacks of videoconferencing for collaborating multidisciplinary teams in regional oncology networks: a scoping review

Factors influencing outcomes of older children with medulloblastoma over 15 years in Peru, a resource‐limited setting

Contact Info

Product

Resources

About